14-day Premium Trial Subscription Sign Up For FreeGet Free

Allscripts Healthcare Solutions Stock Forecast NASDAQ:MDRX

Price Target and Analyst Ratings

Most Recent Rating

On August 06, 2021 "Piper Sandler" gave "$15.00 - $17.00" rating for MDRX. The price target was set to $17.37+1.3%.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2021-08-06 $15.00 - $17.00 Reiterated by Piper Sandler $17.39 $17.37+1.3%
2021-08-06 $17.00 - $19.00 Target Raised by SVB Leerink $17.39 $17.85+4.1%
2021-08-06 $17.00 - $19.00 Target Raised by Royal Bank of Canada $17.39 $17.85+4.1%
2021-05-26 Market Perform Target Raised by SVB Leerink $17.48 $16.00 → $17.00
2021-05-20 Hold Target Raised by Deutsche Bank Aktiengesellschaft $17.17 $15.00 → $17.00
2021-05-06 Buy Target Raised by Canaccord Genuity $15.88 $17.00 → $18.00
2021-05-06 Market Perform Target Raised by SVB Leerink $15.88 $15.00 → $16.00
2021-04-30 Buy Target Raised by Canaccord Genuity $15.56 $17.00 → $18.00
2021-04-30 Market Perform Target Raised by SVB Leerink $15.56 $15.00 → $16.00
2021-04-29 Underweight Initiated by JPMorgan Chase & Co. $15.75
2021-03-08 Buy - Hold Reiterated by Argus $15.16
2021-03-04 Market Perform Target Lowered by SVB Leerink $14.98 $16.00 → $15.00
2021-03-02 Buy - Hold Downgraded by Argus $15.16
2021-02-26 Neutral Target Lowered by Piper Sandler $15.43 $17.00 → $15.00
2021-02-26 Market Perform Target Lowered by SVB Leerink $15.43 $16.00 → $15.00
2021-02-16 Neutral Target Raised by Piper Sandler $17.09 $11.50 → $17.00
2020-11-25 Buy Target Raised by Bank of America $14.18 $14.00 → $16.50
2020-11-11 Hold - Buy Upgraded by Argus $12.42 $14.00
2020-10-23 Neutral - Underweight Downgraded by JPMorgan Chase & Co. $10.92 $9.00 → $11.00
2020-10-19 Outperform - Neutral Downgraded by Robert W. Baird $10.52 $13.00
2020-10-14 Neutral Target Raised by Cantor Fitzgerald $10.90 $9.00 → $13.00
2020-10-14 Market Perform Target Raised by SVB Leerink $10.90 $10.00 → $13.00
2020-08-24 Neutral Target Raised by JPMorgan Chase & Co. $9.17 $8.00 → $9.00
2020-08-11 Underweight Target Raised by Morgan Stanley $8.98 $6.00 → $8.00
2020-08-03 Outperform Target Raised by Royal Bank of Canada $9.29 $8.00 → $10.00
2020-07-31 Market Perform Target Raised by SVB Leerink $9.00 $6.00 → $10.00
2020-07-31 Buy Reiterated by Canaccord Genuity $9.00
2020-07-31 Hold - Neutral Target Raised by Cantor Fitzgerald $9.00 $6.00 → $9.00
2020-07-21 Neutral - Sell Downgraded by Goldman Sachs Group $6.65 $6.50 → $5.50
2020-06-11 Hold Target Lowered by Deutsche Bank $5.86 $11.00 → $9.00
2020-05-13 Underweight Target Raised by Morgan Stanley $5.63 $5.00 → $6.00
2020-05-13 Hold Target Raised by SunTrust Banks $5.63 $6.00 → $7.00
2020-05-10 Buy Reiterated by Royal Bank of Canada $6.40 $8.00
2020-05-08 Market Perform Target Lowered by SVB Leerink $6.40 $8.00 → $6.00
2020-05-08 Neutral Target Lowered by Cantor Fitzgerald $6.40 $8.00 → $6.00
2020-04-22 Buy - Hold Downgraded by Jefferies Financial Group $6.17 $10.50 → $7.00
2020-04-20 Outperform Initiated by Royal Bank of Canada $6.62
2020-04-13 Market Perform Initiated by SVB Leerink $6.58

MDRX Stock Trend

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -22.24% during the next 3 months and, with a 90% probability hold a price between $10.33 and $11.64 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Data

Date Bottom Mid Top
2021-09-20 $13.22 $14.06 $14.91
2021-09-21 $13.15 $13.99 $14.84
2021-09-22 $13.08 $13.93 $14.77
2021-09-23 $13.01 $13.86 $14.70
2021-09-24 $12.95 $13.79 $14.63
2021-09-27 $12.88 $13.72 $14.57
2021-09-28 $12.81 $13.65 $14.50
2021-09-29 $12.74 $13.59 $14.43
2021-09-30 $12.67 $13.52 $14.36
2021-10-01 $12.61 $13.45 $14.29
2021-10-04 $12.54 $13.38 $14.23
2021-10-05 $12.47 $13.31 $14.16
2021-10-06 $12.40 $13.25 $14.09
2021-10-07 $12.33 $13.18 $14.02
2021-10-08 $12.27 $13.11 $13.95
2021-10-11 $12.20 $13.04 $13.89
2021-10-12 $12.13 $12.97 $13.82
2021-10-13 $12.06 $12.91 $13.75
2021-10-14 $11.99 $12.84 $13.68
2021-10-15 $11.93 $12.77 $13.61
2021-10-18 $11.86 $12.70 $13.55
2021-10-19 $11.79 $12.63 $13.48
2021-10-20 $11.72 $12.57 $13.41
2021-10-21 $11.65 $12.50 $13.34
2021-10-22 $11.59 $12.43 $13.27
2021-10-25 $11.52 $12.36 $13.21
2021-10-26 $11.45 $12.29 $13.14
2021-10-27 $11.38 $12.23 $13.07
2021-10-28 $11.31 $12.16 $13.00
2021-10-29 $11.25 $12.09 $12.93

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions Allscripts Healthcare Solutions, Inc. provides information technology and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records, connectivity, hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions. The company’s Clinical and Financial Solutions segment provides integrated clinical software applications and fi... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT